Effects of 5-azacytidine on transfer RNA modification: Comparative study on normal and malignant tissues

Lee Jane Wang Lu, Grace H. Chiang, Kurt Randerath

Research output: Contribution to journalArticle

1 Scopus citations


In general, the treatment of animals with 5-azacytidine (1-β-D-ribofuranosly-4-amino-s-triazine-2(1H)-one) was found to lead to a specific reduction of the 5-methylcytidine (m5C) content of tRNA in tissues, e.g. liver, hepatoma, mammary tumor, and spleen; however, the effect of the drug on post-transcriptional tRNA modification was more general in lymph nodes and in leukemic cells. Many base modifications of L1210 cell tRNA were inhibited, with m5C and dihydrouridine (hU) being affected the most. A positive correlation existed between the extent of inhibition of the formation of m5C and other modified nucleosides and the antitumor activity of the drug.

Original languageEnglish (US)
Pages (from-to)577-584
Number of pages8
JournalLife Sciences
Issue number7
StatePublished - Jan 1 1980


ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this